Abstract
Sampling of mammal communities across the United States during 2022–2023 detected evidence of SARS-CoV-2 antibodies in 3 new species and 2 previously described species and evidence of influenza A antibodies in 2 previously described species. Our analysis provides surveillance and sampling guidance for detection of rare exposure events.
Source: US Centers for Disease Control and Prevention, https://wwwnc.cdc.gov/eid/article/31/8/24-1671_article
____
No comments:
Post a Comment